Back to
VANGUARD GROUP INC
KNSA6 quarters
Position history for
VANGUARD GROUP INC's holdings in KINIKSA PHARMACEUTICALS INTL
As of its last 13F, for Q4 2025, Vanguard Group held 3,112,937 shares of KNSA (Kiniksa Pharmaceuticals International), worth $128.4M. It increased the position by 49,802 shares (+1.6%) from Q3 2025. Vanguard Group held KNSA from Q3 2024 to Q4 2025, across 6 quarterly 13F filings.
Current Value
$128.4M
Current Shares
3.1M
Total Value Change
+$46M
Total Shares Change
-185,319
Quarter-by-Quarter History
Other major holders of KNSA: FMR LLC, BAKER BROS. ADVISORS LP, BlackRock, Inc.